- Report
- September 2024
- 127 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- March 2025
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- December 2022
- 83 Pages
Asia Pacific
From €3640EUR$4,000USD£3,121GBP
- Report
- June 2023
- 118 Pages
Global
From €4095EUR$4,500USD£3,511GBP
The Artificial Retina market is a subset of the Medical Devices industry, focused on the development of retinal implants to restore vision in patients with retinal degenerative diseases. These implants are designed to replace the function of the damaged photoreceptors in the retina, allowing the patient to perceive light and dark patterns. The technology is based on the use of a microelectronic chip, which is surgically implanted in the eye and connected to the remaining healthy retinal cells.
The Artificial Retina market is expected to grow in the coming years, driven by the increasing prevalence of retinal degenerative diseases, the development of new technologies, and the increasing demand for vision restoration.
Some of the companies in the Artificial Retina market include Second Sight Medical Products, Inc., Pixium Vision, Retina Implant AG, and Nano Retina, Inc. Show Less Read more